Compound Detail
CHEMBL148987
Enter ChEMBL ID:
Free Research Context
This compound will appear in recent viewed items on the research home for this browser.
Research home
View demo workspace
Basic Information
| ChEMBL ID | CHEMBL148987 |
| Phase | Preclinical |
| Structure Type | MOL |
| InChI Key | LBSFTZBRVMQPFP-UHFFFAOYSA-N |
1
Targets
2
Activities
1
Assay Types
0
PK Parameters
2
Publications
0
Known Names
Molecular Properties
306.8
MW (Da)
3.11
ALogP
4
HBA
1
HBD
65.1
PSA (Ų)
0.74
QED
0
Ro5 Violations
2
Rot. Bonds
Drug Information
| Molecule Type | Small molecule |
| Availability | Unknown |
| Chirality | Unknown |
Activity Summary
EC50 2 meas. best 6.0
Target Activity Profile
| Target | Type | Best pChEMBL | Mean pChEMBL | Best (nM) | # Data |
|---|---|---|---|---|---|
| MT4 CHEMBL388 | EC50 | 6.0 | 6.0 | 1000.0 | 2 |
Activity Data Samples
Top measurements by pChEMBL value
| Target | Type | Rel. | Value | Units | pChEMBL | Assay | PubMed |
|---|---|---|---|---|---|---|---|
| MT4 | EC50 | = | 1000.0 | nM | 6.0 | Effective concentration against HIV-1 induced cytopathogenicity in MT-4 cells | 8558522 |
| MT4 | EC50 | = | 1000.0 | nM | 6.0 | Concentration required for 50% protection of infected MT-4 cells from wtIIIB-HIV... | 15634015 |
Literature References
| PubMed | DOI | Target Context | # Activities |
|---|---|---|---|
| 8558522 | 10.1021/jm950568w | MT4 | 2 |
| 15634015 | 10.1021/jm040854k | MT4 | 1 |
Data from ChEMBL 36 via Core Engine